Skip to main content

Warning notification:Warning

Unfortunately, you are using an outdated browser. Please, upgrade your browser to improve your experience with HSE. The list of supported browsers:

  1. Chrome
  2. Edge
  3. FireFox
  4. Opera
  5. Safari

Supportive Care SACT Regimens

Denosumab 120mg Therapy

Regimen

Indication

00741a

For the prevention of skeletal related events in adult patients with malignancies involving bone.

Zoledronic Acid Therapy-28 days

Regimen

Indication

00723a

Prevention of skeletal related events in malignancies involving bone metastases

Zoledronic Acid Therapy-3 monthly

Regimen

Indication

00724a

Prevention of skeletal related events in malignancies involving bone metastases

Zoledronic Acid Therapy-6 monthly

Regimen

Indication

00725a

Prevention of skeletal related events in malignancies involving bone metastases

Back to National Cancer Control Programme